Valeant Shares Rise As It Makes Progress on Debt -- Market Talk
November 07 2017 - 8:36AM
Dow Jones News
8:04 ET - Shares of Valeant Pharmaceuticals International jump
12% premarket as the company said it had reduced its debt load
faster than expected. Valeant has used divestitures, such as the
sale of Sprout Pharmaceuticals announced Monday, and the use of
free cash flow to reduce its total debt by $6B since the end of the
1Q 2016. Valeant's long-term debt now stands at $27.14B. Shares are
trading around $13.50 each, down from more than $100 in January
2016. (austen.hufford@wsj.com; @austenhufford)
(END) Dow Jones Newswires
November 07, 2017 08:21 ET (13:21 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Valeant Pharma (NYSE:VRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Valeant Pharma (NYSE:VRX)
Historical Stock Chart
From Apr 2023 to Apr 2024